Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
上海药明生物技术有限公司 Wuxi Biologics
{{company.company_channel.channel_name}}
Media Room
Latest
Photos
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Follow :
X
Company Profile
Media Room
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.title}}
loading
The End
Network Errors Please Retry
{{selectname}}
{{showName}}
{{selectall}}
{{option}}
WuXi Biologics Completed Acquisition of a Drug Product Manufacturing Facility in Germany
2020-04-22 08:00
WuXi Biologics (Suzhou) Successfully Passed First EMA GMP Inspection
2020-04-14 08:00
WuXi Biologics Achieved Remarkable Results in 2019
2020-03-26 21:32
WuXi Biologics Completes Weather-Tight Seal of its Biologics Manufacturing Facility in Ireland
2020-03-11 08:00
WuXi Biologics and Vir Biotechnology Announce Collaboration for Global Development of Antibodies to Treat COVID-19
2020-02-25 21:30
WuXi Biologics Congratulates Immutep on Positive Interim Data for IMP-321
2020-02-24 08:00
WuXi Biologics' Subsidiary WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a Global Vaccine Leader
2020-02-18 18:42
WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a Global Vaccine Leader
2020-02-18 18:18
WuXi Biologics Provides Back-to-work Operation Update Related to the Coronavirus Outbreak
2020-02-12 08:00
WuXi Biologics Provides Operation Update Related to the Coronavirus Outbreak
2020-01-29 10:44
WuXi Biologics Enables Development of Multiple Neutralizing Antibodies for Novel Coronavirus
2020-01-29 10:00
WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany
2020-01-16 10:39
WuXi Biologics and Almirall Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases
2020-01-09 17:10
WuXi Biologics Congratulates OncoImmune on FDA Clearance of IND Application for Next Generation anti-CTLA-4 Antibody ONC-392
2020-01-02 08:08
WuXi Biologics Receives "Special Award to Investors in Ireland" from Asia Matters
2019-12-23 16:26
WuXi Vaccines to Build a $240 Million Manufacturing Facility in Ireland
2019-11-23 01:55
WuXi Biologics Reports Outstanding Interim Results
2019-08-19 22:09
WuXi Biologics to Expand Integrated Biologics Conjugation Solution Center to Include Commercial Manufacturing
2019-06-21 08:39
WuXi Biologics Signed Letter of Intent for Long-Term Vaccine Manufacturing Contract
2019-05-21 07:30
WuXi Biologics Commenced Construction of a 48,000 L Integrated Manufacturing Center for Innovative Biologics in Chengdu
2019-05-16 15:39
1
3
4
5
6
7
8